Cardiac Abnormalities in Stroke Prevention and Risk of Recurrence

NCT06398366 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2025-01-23

No results posted yet for this study

Summary

This is a multi-center retrospective analysis of consecutive adult patients with cryptogenic stroke patients following a comprehensive workup for the underlying stroke etiology. Patients will be eligible for inclusion if the index stroke event occurred between 1/1/2016 and 06/30/2022.

Conditions

  • Cryptogenic Stroke

Sponsors & Collaborators

  • Duke University

    collaborator OTHER
  • Covenant Health, Canada

    collaborator OTHER
  • University of Colorado, Denver

    collaborator OTHER
  • Medical University of South Carolina

    collaborator OTHER
  • University of Maryland, Baltimore

    collaborator OTHER
  • University of Pennsylvania

    collaborator OTHER
  • Emory University

    collaborator OTHER
  • University of Chicago

    collaborator OTHER
  • University of Tennessee

    collaborator OTHER
  • Ohio State University

    collaborator OTHER
  • West Virginia University

    collaborator OTHER
  • Mayo Clinic

    collaborator OTHER
  • Boston Medical Center

    collaborator OTHER
  • Rhode Island Hospital

    collaborator OTHER
  • Beth Israel Lahey Health

    collaborator UNKNOWN
  • Christiana Care Health Services

    collaborator OTHER
  • Henry Ford Health System

    collaborator OTHER
  • Thomas Jefferson University

    collaborator OTHER
  • University of Iowa

    collaborator OTHER
  • University of California, Los Angeles

    collaborator OTHER
  • Allina Health System

    collaborator OTHER
  • Yale University

    collaborator OTHER
  • The University of Texas Health Science Center, Houston

    collaborator OTHER
  • Dartmouth-Hitchcock Medical Center

    collaborator OTHER
  • Virginia Commonwealth University

    collaborator OTHER
  • The Cooper Health System

    lead OTHER

Principal Investigators

  • Jesse Thon · Cooper Health System

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-14
Primary Completion
2025-05-30
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06398366 on ClinicalTrials.gov